NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a lifestyle and consumer packaged goods company, announces the launch of "Men's Health on Tap," a new podcast series hosted by distinguished doctors, Dr. John P. Sfakianos, MD, Associate Professor, Department of Urology at the Icahn School of Medicine, and Dr. Steven A. Kaplan, MD, Professor, Department of Urology at the Icahn School of Medicine. The podcast aims to break down stigmas around men's health and invite ...

Growth Strategies and Profitability - Tilray's Q1 FY25 revenue reached a record $200 million, up 13% YoY, with gross profit increasing by 35% [2] - The company focuses on profitable sales growth over market share expansion, emphasizing premium branding, genetics, and innovation [2] - Tilray maintains a strong balance sheet with $250 million in cash and a debt-to-equity ratio of 1.75 [2] - The diversified portfolio, including cannabis, hemp food, beverages, and pharmaceutical distribution, is profitable [2] U.S. Market Entry and Beverage Expansion - Tilray is entering the U.S. market with hemp-derived Delta-9 THC drinks, targeting 17 to 19 states with brands like Happy Flower, 420 Fizz, and Fizzy Jane [3] - The company sees a billion-dollar opportunity in THC-infused beverages, driven by younger consumers shifting away from alcohol [3] - Tilray leverages its existing distribution network, including 700 beer distributors, 10 manufacturing facilities, and over 17,000 accounts [3] - The company is cautious about direct U.S. cannabis market entry, waiting for clearer regulatory frameworks [4] Craft Beer Strategy and Market Focus - Tilray's craft beer portfolio, including SweetWater and Montauk, sells 15 million cases annually across 19 brands [3] - The company is shifting its strategy to focus on core markets, such as Georgia and New York, rather than spreading thinly across multiple states [3] Lifestyle Brands and U.S. Rescheduling - Tilray's success is not dependent on U.S. cannabis rescheduling, as it already has a significant consumer products business in the U.S. [5] - The company positions itself as a lifestyle brand, with a portfolio including non-alcoholic beverages, hemp food, and beer [5] - Tilray plans to continue acquisitions and growth regardless of cannabis reform [5] International Market Challenges and Opportunities - Tilray faces challenges in international markets, such as lost distribution in Israel, but sees growth potential in Germany and other countries with liberalizing medical cannabis regulations [5] - The company holds a 45% market share in Canada's cannabis drinks segment, providing a foundation for international expansion [5] Future Growth: Innovation and Diversification - Tilray's future growth relies on innovation and leveraging its diversified business model, including non-alcoholic and energy drinks like Liquid Love [6] - The company emphasizes the importance of distribution synergies, particularly through beer distributors [6] - Tilray remains confident in its long-term prospects, focusing on strategic growth and profitability [6]

LITTLETON, Colo., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), announced today the release of its seasonal Funslinger Lager, a crisp and easy-drinking beer that’s the perfect companion to kick off winter’s adventures. The Funslinger 12pk and draft is available exclusively in Colorado; Funslinger is also part of Breckenridge Brewery’s variety 15pk available at select retailers across the U.S. Funslinger Lager celebrates local art t ...

I am a market enthusiast and part-time trader. I started writing for Seeking Alpha in 2011, and it has been a tremendous opportunity and learning experience. I have been interested in the markets since elementary school, and hope to pursue a career in the investment management industry. I have been active in the markets for several years, and am primarily focused on long/short equities. I hold a Bachelor of Science Degree from Lehigh University, where I double majored in Finance and Accounting, with a minor ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38594 | --- | --- | |----------------------------------------------------------------------------------------------------------- ...

Tilray Brands, Inc. (NASDAQ:TLRY) Q1 2025 Earnings Conference Call October 10, 2024 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs and Communications Officer Irwin Simon - Chairman and CEO Carl Merton - CFO Denise Faltischek - Chief Strategy Officer and Head of International Blair MacNeil - President of Tilray Canada Conference Call Participants Kaumil Gajrawala - Jefferies Aaron Grey - Alliance Global Partners Matt Bottomley - Canaccord Genuity Bill Kirk - ROTH MKM Michael Lavery ...

About the Publisher - Proactive provides fast, accessible, and actionable business and finance news content to a global investment audience [1] - The company's content is produced independently by experienced and qualified teams of news journalists [1] - Proactive's news team spans key finance and investing hubs globally, including London, New York, Toronto, Vancouver, Sydney, and Perth [2] Market Expertise - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [2] - The team delivers news and insights across various sectors, including biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Use of Technology - Proactive is a forward-looking and enthusiastic adopter of technology, equipping its human content creators with decades of expertise and experience [3] - The company occasionally uses automation and software tools, including generative AI, to assist and enhance workflows [4] - All content published by Proactive is edited and authored by humans, adhering to best practices in content production and search engine optimization [4]

For the quarter ended August 2024, Tilray Brands, Inc. (TLRY) reported revenue of $200.04 million, up 13.1% over the same period last year. EPS came in at -$0.04, compared to -$0.10 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $219.36 million, representing a surprise of -8.81%. The company delivered an EPS surprise of +20.00%, with the consensus EPS estimate being -$0.05. While investors closely watch year-over-year changes in headline numbers -- revenue and earn ...

Tilray Brands, Inc. (TLRY) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 20%. A quarter ago, it was expected that this company would post a loss of $0.02 per share when it actually produced a loss of $0.04, delivering a surprise of -100%. Over the last four quarters, the company has surpas ...

Revenue Growth - Q1 net revenue increased 13% year-over-year to $200 million[1][3] - Net revenue grew by 13% to $200,044 from $176,949[19] - Beverage alcohol net revenue surged 132% to $56.0 million in Q1[3] - Beverage alcohol business revenue surged to $55,972, representing 28% of total revenue[23] - Net beverage alcohol revenue surged 131.6% to $56.0 million in Q3 2024 from $24.2 million in Q3 2023[27] Gross Margin and Profit - Gross margin increased by 500 basis points to 30% in Q1[1][3] - Gross profit increased by 35% to $59,706 from $44,196[19] - Cannabis net revenue reached $61.2 million with a gross margin of 40% in Q1[3] - Cannabis adjusted gross margin improved to 40% in Q3 2024 from 35% in Q3 2023[27] Business Segments - Distribution net revenue was $68.1 million with a gross margin of 12% in Q1[3] - Wellness net revenue grew 11% to $14.8 million in Q1[3] - Cannabis business revenue declined to $61,249, accounting for 31% of total revenue[23] - Distribution business revenue slightly decreased to $68,071, making up 34% of total revenue[23] - Wellness business revenue rose to $14,752, contributing 7% of total revenue[23] - Net cannabis revenue for Q3 2024 was $61.2 million, a decrease of 12.9% compared to $70.3 million in Q3 2023[25] - Canadian adult-use cannabis revenue declined by 19.6% to $57.2 million in Q3 2024 from $71.2 million in Q3 2023[25] - International cannabis revenue decreased by 14.5% to $12.2 million in Q3 2024 from $14.3 million in Q3 2023[25] Financial Performance - Adjusted EBITDA was $9.3 million in Q1 compared to $10.7 million in the prior year quarter[3] - Operating loss widened by 6% to $(36,570) from $(34,362)[20] - Net loss decreased by 38% to $(34,652) from $(55,863)[20] - Adjusted EBITDA for Q3 2024 was $9.3 million, down 13.0% from $10.7 million in Q3 2023[27] - Net loss narrowed to $34.7 million in Q3 2024 from $55.9 million in Q3 2023, a 38% improvement[30] Cash Flow and Assets - Total assets increased to $4,261,867 from $4,221,665[18] - Net cash used in operating activities increased by 123% to $(35,307) from $(15,842)[21] - Cash and marketable securities decreased to $280.1 million as of August 31, 2024, from $466.5 million a year earlier[27] - Free cash flow was negative $42.0 million in Q3 2024, compared to negative $19.7 million in Q3 2023[33] - Working capital increased to $432.3 million as of August 31, 2024, from $292.0 million a year earlier[27] Regulatory and Market Developments - German medical cannabis flower revenue increased by 50% following legalization[1] - Tilray Alternative Beverages launched in October to fuel key U.S. markets with hemp-derived Delta-9 THC products[1] - The company anticipates improved regulatory changes in the cannabis industry following the upcoming U.S. Presidential elections[2]